HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Targeted therapies for epithelial cancers: in vivo efficacy of the BCL-2/BCL-XL inhibitor 2-MeAA.

AuthorsPamela S Schwartz, David M Hockenbery
JournalCancer biology & therapy (Cancer Biol Ther) Vol. 6 Issue 3 Pg. 465-6 (Mar 2007) ISSN: 1538-4047 [Print] United States
PMID17471026 (Publication Type: Comment, Journal Article)
Chemical References
  • 2-methoxyantimycin
  • Proto-Oncogene Proteins c-bcl-2
  • bcl-X Protein
  • Antimycin A
Topics
  • Antimycin A (analogs & derivatives, therapeutic use)
  • Carcinoma (drug therapy)
  • Cell Line, Tumor
  • Humans
  • Proto-Oncogene Proteins c-bcl-2 (antagonists & inhibitors)
  • bcl-X Protein (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: